Literature DB >> 31647197

A transdiagnostic model of psychiatric symptom co-occurrence and autism spectrum disorder.

Craig Rodriguez-Seijas1, Kenneth D Gadow2, Tamara E Rosen1, Hyunsik Kim1, Matthew D Lerner1, Nicholas R Eaton1.   

Abstract

Understanding whether the co-occurrence of psychiatric symptoms within autism spectrum disorder (ASD) are specific to the ASD diagnosis or reflect similar higher-order patterns observed in both ASD and non-ASD samples, or a confluence of the two, is of critical importance. If similar, it would suggest that comorbid psychiatric conditions among individuals with ASD are not symptoms of specific, non-ASD psychiatric disorders per se, but reflect a general liability to psychopathology associated with ASD. To this end, the current study examined whether the higher-order structure of co-occurring psychiatric symptoms was the same within ASD and non-ASD youth. Parents of clinic-referred youth with (n = 280) and without (n = 943) ASD completed a DSM-IV-referenced psychiatric symptom rating scale. A confirmatory factor analytic framework was used to examine four levels of measurement invariance across groups to determine the extent to which transdiagnostic factors were comparable. Transdiagnostic factors were characterized by symptoms of the same disorders (configural invariance) and the same factor loadings across groups (metric invariance). Furthermore, both groups evidenced equivalent numbers of symptoms of most psychiatric conditions with the notable exceptions of attention deficit hyperactivity disorder (ADHD) and social anxiety (partial strong invariance), which were higher in the ASD sample. It was concluded that disparities in the co-occurrence of psychiatric symptoms between youth with and without ASD may be largely reflective of transdiagnostic factor level differences associated with ASD and not indicative of the ASD diagnosis per se. However, for ADHD and social anxiety, there appears to be some specific associations with the ASD diagnosis. Autism Res 2020, 13: 579-590.
© 2019 International Society for Autism Research, Wiley Periodicals, Inc. LAY SUMMARY: Few transdiagnostic dimensions relate common mental disorder diagnoses with one another. These dimensions explain psychiatric comorbidity (i.e., the finding that many persons possess several disorder diagnoses simultaneously). However, it is unclear if these dimensions differ among children with autism spectrum disorder (ASD), compared with their non-ASD counterparts. The results of this study demonstrate that underlying transdiagnostic dimensions are similar in both ASD and non-ASD children. However, there appear to be ASD-specific differences when it comes to social anxiety and attention deficit hyperactivity disorder. © 2019 International Society for Autism Research, Wiley Periodicals, Inc.

Entities:  

Keywords:  autism spectrum disorder; comorbidity; factorial invariance; transdiagnostic factors

Mesh:

Year:  2019        PMID: 31647197     DOI: 10.1002/aur.2228

Source DB:  PubMed          Journal:  Autism Res        ISSN: 1939-3806            Impact factor:   5.216


  4 in total

1.  Trajectories of co-occurring psychopathology symptoms in autism from late childhood to adulthood.

Authors:  James B McCauley; Rebecca Elias; Catherine Lord
Journal:  Dev Psychopathol       Date:  2020-10

2.  Domains of the autism phenotype, cognitive control, and rumination as transdiagnostic predictors of DSM-5 suicide risk.

Authors:  Darren Hedley; Mirko Uljarević; Ru Ying Cai; Simon M Bury; Mark A Stokes; David W Evans
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

3.  Higher-order dimensions of psychopathology in a neurodevelopmental transdiagnostic sample.

Authors:  Joni Holmes; Silvana Mareva; Marc P Bennett; Melissa J Black; Jacalyn Guy
Journal:  J Abnorm Psychol       Date:  2021-11

4.  Lifetime co-occurring psychiatric disorders in newly diagnosed adults with attention deficit hyperactivity disorder (ADHD) or/and autism spectrum disorder (ASD).

Authors:  Artemios Pehlivanidis; Katerina Papanikolaou; Vasilios Mantas; Eva Kalantzi; Kalliopi Korobili; Lida-Alkisti Xenaki; Georgia Vassiliou; Charalambos Papageorgiou
Journal:  BMC Psychiatry       Date:  2020-08-26       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.